The oligonucleotides clinical trial analysis report delivers important insights into ongoing research on 600+ ...

A stem cell donor match gave a 12-year-old child with thalassemia a second chance at life, highlighting the urgent need for ...

Hongene Biotech shows advanced oligonucleotide CDMO capabilities via support of SiranBio’s dual-target siRNA programme: Singapore Saturday, May 9, 2026, 16:00 Hrs [IST] Hongene ...

​The disorder, which often requires blood transfusions every fortnight, affects approximately 1.3 million people living with ...

On World Thalassemia Day 2026, learn why thalassemia remains a major yet preventable health burden in India, and how ...

The Trifill Pro and Rejuran sessions addressed my skin at a structural level while the Saborino masks cost a fraction of that ...

The decision by the Centers for Disease Control and Prevention (CDC) to stop recommending giving infants a dose of the hepatitis B vaccine within 24 hours after birth is likely to lead to hundreds of ...

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced the primary endpoint was met in the Phase 2b portion of the AZURE-1 study evaluating brelovitug, an ...

Hemoglobin is a vital protein found in red blood cells and its primary function is to transport oxygen from the lungs to various tissues throughout the body. According to Finnish reference values, ...

The rate of hepatitis B virus vaccinations given to newborns fell by 10 percentage points between 2023 and 2025, to just over 73%, according to new research published in JAMA. After the COVID pandemic ...

Hypoxic environments modulate downstream gene expression via activation of the hypoxia-inducible factor (HIF) signaling pathway, which facilitates adaptive responses to low oxygen. Under hypoxic ...

The Centers for Disease Control and Prevention (CDC) is no longer recommending giving all infants a dose of the hepatitis B vaccine within 24 hours after birth, approving a sweeping and highly ...